Vascular Insights LLC
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2016–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Vascular ranks #43,903 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
- #43,903
- of 49,997 US assignees by volume
- 21st percentile
- by Innovation Score (26.8/100)
- 23.2
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R43903 · US Corporation #43,903 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #43,903/49,997
- PHOTO-FINISH Valterra Products
- CPC-NARROW A61B · 3 areas
- INNOV-THIN 26.8/100
- CLAIMS-DENSE 23.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Valterra Products, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Vascular’s 26.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Vascular
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Vascular Insights · this assignee 27
Vascular Insights · this assignee
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Vascular's Innovation Score is 26.8/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Vascular?
Each dot is one of Vascular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vascular’s own 23.2 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Vascular's grants concentrate
Vascular Insights LLC is a focused PatentsView assignee: 3 CPC subclasses with 50% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (4 grants) versus a trough of 2 in 2017. By volume, Vascular sits between Valterra Products, LLC and VeChain Global Technology, S.AR.L.
Who files at Vascular's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Valterra Products
Valterra Products, LLC
6 patents
- Valyant AI
Valyant AI, Inc.
6 patents
- Variable
Variable, Inc.
6 patents
- Variperm Energy S…
Variperm Energy Services Inc.
6 patents
- Vasper Systems
Vasper Systems, LLC
6 patents
- Vaughn Realty Ven…
Vaughn Realty Ventures LLC
6 patents
- Vaztec
Vaztec, LLC
6 patents
- Vechain Global Te…
VeChain Global Technology, S.AR.L
6 patents
- Vascular Insights ◀
Vascular Insights LLC
6 patents
What this shows Vascular holds 6 patents at rank #43,927, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Vascular
By rank, the assignees closest to #43,927 in granted patent volume.
- Valterra Products, LLC #43,923 · 6 patents
- Valyant AI, Inc. #43,924 · 6 patents
- Variable, Inc. #43,925 · 6 patents
- Variperm Energy Services Inc. #43,926 · 6 patents
- Vasper Systems, LLC #43,928 · 6 patents
- Vaughn Realty Ventures LLC #43,929 · 6 patents
- Vaztec, LLC #43,930 · 6 patents
- VeChain Global Technology, S.AR.L #43,931 · 6 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Vascular's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Vascular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 21st percentile higher than 21% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 4 | 66.7% |
| 2017 | 2 | 33.3% |
Which technologies does Vascular Insights LLC patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Vascular Insights LLC's patent record in context - here's where to go next.
- Vascular Insights LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 50% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #43,903 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Vascular Insights LLC against Valterra Products, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.